Jill C. Milne

CIK: 0001644246

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (87.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BCRX

BIOCRYST PHARMACEUTICALS INC

Director

ATXS

Astria Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 31, 2026
Award(A)
Direct
1.3K shares at avg. $9.70$12K
BCRX
BIOCRYST PHARMACEUTICALS INC
Jun 11, 2026
Award(A)
Direct
15.3K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
May 29, 2026
Award(A)
Direct
1.3K shares at avg. $8.91$11K
BCRX
BIOCRYST PHARMACEUTICALS INC
Feb 27, 2026
Award(A)
Direct
528 shares at avg. $8.75$5K
BCRX
BIOCRYST PHARMACEUTICALS INC
Jan 23, 2026
Award(A)
Direct
2.6K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Jan 23, 2026
Award(A)
Direct
12.3K shares-
ATXS
Astria Therapeutics, Inc.
Jan 23, 2026
Disposition(D)
Direct
4.4K shares-
ATXS
Astria Therapeutics, Inc.
Mar 21, 2025
Award(A)
Stock Option (Right to Buy)
Direct
761K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	1,288	$9.70	$12,494	Direct
Jun 11, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	15,294	-	$0	Direct
May 29, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	1,262	$8.91	$11,244	Direct
Feb 27, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	528	$8.75	$4,620	Direct
Jan 23, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	2,582	-	$0	Direct
Jan 23, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	12,272	-	$0	Direct
Jan 23, 2026	ATXS Astria Therapeutics, Inc.	Disposition(D)	4,377	-	$0	Direct
Mar 21, 2025	ATXS Astria Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	761,000	-	-	Direct

1-8 of 8 transactions

About Milne Jill C.

Milne Jill C. (SEC CIK 0001644246) files insider reports with the SEC as Director of BIOCRYST PHARMACEUTICALS INC (BCRX) and CEO and President of Astria Therapeutics, Inc. (ATXS).

Signal8 holds 8 ownership filings by Milne Jill C. (1 Form 3, 7 Form 4), filed between Mar 25, 2025 and Sep 2, 2026. Those filings report 8 transactions, from Mar 21, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Milne Jill C.'s filings is in DURHAM, NC.

Recent filings by Milne Jill C.

Aug 31, 2026: Grant or award of BCRX shares (Form 4, code A).
Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
May 29, 2026: Grant or award of BCRX shares (Form 4, code A).
Feb 27, 2026: Grant or award of BCRX shares (Form 4, code A).
Jan 23, 2026: Grants or awards of BCRX shares (2 lines, Form 4, code A).

Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)

Stonehouse Jon P, Director
MILANO VINCENT, Director
McKee Amy E, Director
Frank Steven, Director
Galson Steven K, Director
LEVIN ALAN G, Director

How to read Form 4 transaction codes